Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations

Journal of the National Cancer Institute

Volumn 90, Issue 11, 1998, Pages 841-845

  Schorge, John O ^a,b   Muto, Michael G ^a   Welch, William R ^b   Bandera, Christina A ^d   Rubin, Stephen C ^d   Bell, Debra A ^c   Berkowitz, Ross S ^a   Mok, Samuel C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PERITONEUM CANCER; RECEPTOR BINDING; X CHROMOSOME INACTIVATION;

EID: 0032479005     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.11.841     Document Type: Article

References (29)

1. Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer-Verlag, 1994.
2. Berek JS. Epithelial ovarian cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd ed. Baltimore: Williams & Wilkins, 1994:327-75.
3. Altaras MM, Aviram R, Cohen I, Cordoba M, Weiss E, Beyth Y. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol Oncol 1991;40:230-6.
4. Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol 1990;74:89-95.
5. Lele SB, Piver MS, Matharu J, Tsukada Y. Peritoneal papillary carcinoma. Gynecol Oncol 1988;31:315-20.
6. Dalrymple JC, Bannatyne P, Russell P, Solomon HJ, Tattersall MH, Atkinson K, et al. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 1989;64:110-5.
7. Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 1993;50:347-51.
8. Tobacman JK, Greene MH, Tucker MA, Costa J, Kase R, Fraumeni JF Jr. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 1982; 2:795-7.
9. Piver MS, Jishi MF, Tsukada Y, Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993;71:2751-5.
10. Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol 1990;21: 99-110.
11. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992;84:1793-8.
12. Li S, Han H, Resnik E, Carcangiu ML, Schwartz PE, Yang-Feng TL. Advanced ovarian carcinoma: molecular evidence of unifocal origin. Gynecol Oncol 1993;51:21-5.
13. Gallion HH, Guarino A, DePriest PD, van Nagell JR Jr, Vaccarello L, Berek JS, et al. Evidence for a unifocal origin in familial ovarian cancer. Am J Obstet Gynecol 1996;174: 1102-6; discussion 1106-8.
14. Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, et al. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 1993;48: 5-10.
15. Park TW, Felix JC, Wright TC Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res 1995;55:4793-6.
16. Mok CH, Tsao SW, Knapp RC, Fishbaugh PM, Lau CC. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 1992;52:5119-22.
17. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, et al. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 1995;55:490-2.
18. Moll UM, Valea F, Chumas J. Role of p53 alteration in primary peritoneal carcinoma. Int J Gynecol Pathol 1997;16:156-62.
19. Bandera CA, Schorge JO, Muto MG, Berkowitz RS, Rubin SC, Mok SC. Germline BRCA1 mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol. In press.
20. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, et al. Potential role of the inactivated X chromosome in ovarian epithelial tumor development. J Natl Cancer Inst 1996; 88:510-8.
21. Edelson MI, Lau CC, Colitti CV, Welch WR, Bell DA, Berkowitz RS, et al. A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene 1998;16: 197-202.
22. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
23. Marshal RD, Lester SC, Sklar J. Clonal analysis by study of X chromosome inactivation in formalin-fixed paraffin-embedded tissue [published erratum appears in Cancer Res 1994;54: 1873]. Cancer Res 1993;53:4676-9.
24. Kopp P, Jaggi R, Tobler A, Borisch B, Oestreischer M, Sabacan L, et al. Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue. Mol Cell Probes 1997;11:217-28.
25. Vogelstein B, Fearon ER, Hamilton SR, Preisinger AC, Willard HF, Michelson AM, et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 1987;47:4806-13.
26. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecological cancer. Vol 21. Stockholm: FIGO, 1991:238-9.
27. Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, et al. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993;53:1489-92.
28. Mutter GL, Chaponot ML, Fletcher JA. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 1995;146:501-8.
29. Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, Tattersall MH. Multifocal tumorigenesis in the upper female genital tract -implications for staging and management. Int J Gynecol Pathol 1985;4:192-210.